This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Drug Channels Institute’s (DCI’s) latest analysis finds that participants in the specialtypharmacymarket continue to get more diverse—although revenues remain highly concentrated. Read on for DCI’s latest overview of the 2023 marketplace and revenues of the biggest market participants, along with key specialtypharmacy trends.
As many of you know, hospitals and health systems have emerged as significant participants in the specialtypharmacy industry. A new American Society of Hospital Pharmacists (ASHP) survey provides fresh insights into these specialtypharmacies. drug channels gets most of the attention. d/b/a Drug Channels Institute.
Informa Connect's Hub and SpecialtyPharmacy Models West. September 14-15, 2022 Sheraton San Diego Hotel & Marina | San Diego, CA www.informaconnect.com/hub-specialty-pharmacy-west. Delivered as a Hybrid Event. Drug Channels readers will save 10% off the current registration rate when they use code 22DC10 *.
For 2022, pharmacy benefits managers (PBMs) and insurers expanded their dominance over specialty dispensing, though both hospitals and physician practices are growing their share of the market. As predicted last year, Walgreens’ specialtypharmacy business has collapsed, which led to a slightly less concentrated industry.
Informa Connect’s Hub and SpecialtyPharmacy Models East. June 28-30, 2022 | Sheraton Parsippany | Parsippany, NJ www.informaconnect.com/hub-specialty-pharmacy. For 2022 only, Hub and SpecialtyPharmacy Models and PAP – Patient Assistance & Access Programs are under the same roof. Attorney, U.S.
Asembia’s SpecialtyPharmacy Summit 2022. Asembia's SpecialtyPharmacy Summit 2022 is back! This is a must-attend event for anyone connected to specialtypharmacy. Plus, Doug Long from IQVIA and I will again lead the Featured Session, titled The SpecialtyPharmacy Industry Update and Outlook.
Today’s guest post comes from Bill Dupere, Practice Lead and VP of Market Access Solutions and Eric Willis, VP of Operations Hub and Reimbursement Services at TrialCard. To learn more, please contact Trialcard at sales@trialcard.com or visit them in booth #416 at the upcoming Asembia SpecialtyPharmacy Summit from October 26 to 29, 2021.
One important update to the figures below: We (and many others) had significantly underestimated Walgreens' revenues and market share. billion figure was roughly accurate for the AllianceRx Walgreens Pharmacy business. Consequently, its market share is closer to 10%, compared with the 3% that we reported.
Last week, we documented the substantial concentration of dispensing revenues for specialty drugs. See The Top 15 SpecialtyPharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents. Today, we examine how manufacturers’ specialty networks contribute to this concentration.
In May, I recorded a brief video webinar for an on-demand business education session at Asembia's 2020 SpecialtyPharmacy Summit Virtual Experience. You can watch the full video below.
specialtypharmacies. As you will note below, the specialtypharmacy industry remains quite diverse— despite the concentration of dispensing revenues within a small number of companies. It’s time for Drug Channels Institute’s annual update of the number of U.S. Fortunately, I had outstanding research assistance.
Last week, we documented the substantial concentration of dispensing revenues for specialty drugs. See The Top 15 SpecialtyPharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents. Today, we examine how manufacturers’ specialty networks contribute to this concentration.
This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Update: Buy-and-Bill Market Trends. In Drug Channels Institute's list of the top 15 pharmacies of 2020 , we show that many of the largest U.S. Click here to see the original post and comments from May 2021.
For updated data on hospital-owned specialtypharmacies, see Chapter 3 of DCI's new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. As many of you know, hospitals and health systems have emerged as significant participants in the specialtypharmacy industry.
Last week, Paula and I had the pleasure of attending Asembia’s 2023 SpecialtyPharmacy Summit at the wonderful Wynn Las Vegas. I offer reflections on my keynote session with Seema Verma, share my experiences during the featured session, and highlight some crucial specialty industry trends.
In Drug Channels Institute's list of the top 15 pharmacies of 2019 , we show that many of the largest U.S. pharmacies are now central-fill mail and specialtypharmacies operated by PBMs and insurers. I see upside for specialtypharmacies in the aftermath of the pandemic. d/b/a Drug Channels Institute.
In this issue: Green Monster : The 340B market hits new highs in 2021 Not-Free Agents : Big 340B profits for CVS, Walgreens, Express Scripts, et al Batter Up : Fixing the insulin market Pinch Hitters : Walgreens bets on robots Plus, Dr. Glaucomflecken helps UnitedHealthcare celebrate Doctors’ Day! Hope to see you there!
Like many of you, I was disappointed that Asembia had to cancel its 2020 SpecialtyPharmacy Summit. You can view them for FREE if your registration to the 2020 SpecialtyPharmacy Summit was transferred to the 2021 Summit. Click here to register for access to Asembia’s SpecialtyPharmacy Summit Virtual Experience. (You
The largest 15 pharmacies accounted for more than 75% of total dispensing revenues from retail, mail, long-term care, and specialtypharmacies. The top 15's share dipped slightly compared with their 2021 share, due primarily to the significant revenue losses for Walgreens Boots Alliance’s AllianceRx Walgreens Pharmacy.
Stop running in circles—It’s time to unlock proven strategies to propel market access. A program driven by market dynamics and led by champions of channel strategy, join your peers now to master the complexities of pharmacy and distribution models to accelerate market access—It's all happening December 10-12.
Join Dr. Fein as he helps you and your team stay on top of the latest trends, market data, and strategies for pharmacy benefit management. Pharmacies and Pharmacy Benefit Managers. Anyone who registered for the entire series will receive an email with a link to access the April event. WHAT YOU WILL LEARN.
Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Learn more about AssistRx’s specialty therapy initiation and patient support services at Asembia's SpecialtyPharmacy Summit on May 2-5, 2022. Click here to schedule your meeting.
Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Stacey discusses digital hubs and the affordability advantages they offer both patients on specialty therapies and their health care providers.
Nonetheless, taxpayersprimarily via Medicare and Medicaidwill continue to dominate the employer-sponsored insurance market. Like it or not, vertically integrated insurers, PBMs, specialtypharmacies, and providers will continue to prosper.
He goes on to describe four new categories of patient solutions and pharmacy models specific to this growing market segment. To learn more about CoAssist and AssistRx specialty therapy initiation and patient support services, click here to schedule a meeting with AssistRx at the Asembia SpecialtyPharmacy Summit on May 2-5, 2022.
The 340B contract pharmacymarket shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. For an updated look at what’s next for the 340B contract pharmacymarket, join Adam J.
This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. The 340B contract pharmacymarket shows little sign of slowing down. For an updated look at what’s next for the 340B contract pharmacymarket, join Adam J.
View the Agenda Snapshot Enhance Patient Service, Network Design, and Channel Strategies to Improve Patient Access and Support In its 8th year, the Specialty Network and Patient Support Services Summit is an important event for senior leaders in patient access, trade, channel, market access, brand and account strategy.
In Drug Channels Institute's list of the top 15 pharmacies of 2020 , we show that many of the largest U.S. market participants are now central-fill mail and specialtypharmacies operated by PBMs and insurers. As we look ahead, CVS Health and Cigna’s Express Scripts seem best positioned for further growth.
Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Stacey discusses how a patient support vendor can help specialtypharmacy patients attain prior authorizations and access critical therapies.
Pharmacies and Pharmacy Benefit Managers is a definitive, nonpartisan resource that includes the most current information about pharmacy dispensing channels, third-party payers, pharmacy benefit managers (PBMs), patients’ financial contributions, government regulations, and much more.
Prescription Market (press release) We’re offering special discounted pricing if you order before March 28, 2022. Pharmacies and Pharmacy Benefit Managers , our 13th edition, provides a comprehensive, fact-based, and non-partisan tool for understanding the entire U.S. The 2022 Economic Report on U.S.
Year after year, the life science industry marks Informa Connect’s Trade and Channel Strategies as the “go-to” event for trade, channel, market access, account strategy and brand professionals. The full agenda for this year’s Trade and Channel Strategies conference is available now!
Last week, news broke that Prime Therapeutics is expanding its relationship with Cigna’s Express Scripts to include mail and specialtypharmacy dispensing. So far, there's been very little written about this transaction.
Last week, news broke that Prime Therapeutics is expanding its relationship with Cigna’s Express Scripts to include mail and specialtypharmacy dispensing. So far, there's been very little written about this transaction.
Fein will share his latest thinking on a wide range of topics, including: The prescription market in 2022 Benefit design and plan sponsor strategies Federal and state drug pricing policy The 340B Drug Pricing Program Consolidation and vertical integration Specialtypharmacy trends Copay accumulators, maximizers, and utilization management tools Biosimilars (..)
This important event convenes key stakeholders including manufacturers, specialtypharmacies, hubs, payers, PBMs, physicians and more to explore strategies for developing and integrating hub programs and other patient-centric services to ensure product access and optimal reimbursement. Arquette, R.Ph., Arquette, R.Ph., REGISTER TODAY.
Today’s guest post comes from William Dupere, Practice Lead and Vice President of Market Access at TrialCard. Bill discusses specific barriers to access, affordability, and adherence in the specialtypharmacy patient journey. To learn more about TrialCard’s patient access solutions, please visit their Resources page.
Nonetheless, taxpayers—primarily via Medicare and Medicaid—will continue to dominate the employer-sponsored insurance market. Like it or not, vertically integrated insurers, PBMs, specialtypharmacies, and providers will continue to prosper.
The largest players all had bigger slices of the revenue pie, due to the growth at specialtypharmacies and multiple transactions that shifted market share among the vertically integrated companies. prescription dispensing revenues reached a record $465 billion in 2020.
The largest players all had bigger slices of the revenue pie, due to the growth at specialtypharmacies and multiple transactions that shifted market share among the vertically integrated companies. prescription dispensing revenues reached a record $465 billion in 2020.
In this issue: Payers confess: Patients lose from copay accumulators Humana joins the Express Scripts GPO Hospitals vs. PBMs over specialtypharmacy white bagging Let’s all follow the Buy-and-Bill Dollar! Plus, entrepreneurial pharmacy owner Dave Marley demonstrates the power of innovation.
The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceutical market—and some channels are benefiting more than others. As you will see below, mail and specialtypharmacies’ purchases of products that are eligible for 340B discounts have grown by an incredible 56% per year since 2017.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content